Monday, 26 Apr 2021 10:52 PM MYT
Dr Kalaiarasu M Periasamy said based on data from the Medicines and Healthcare Products Regulatory Agency (MHRA) and the European Medicines Agency (EMA), there have been 168 cases of thrombosis detected worldwide since March and, during that period, about 21.6 million individuals worldwide had received the AstraZeneca vaccine jab. Reuters pic
Subscribe to our Telegram channel for the latest updates on news you need to know.
PUTRAJAYA, April 26 The number of blood clot or thrombosis cases after receiving the AstraZeneca Covid-19 vaccine jab is low and rare, said the Health Ministry’s (MOH) Covid-19 Vaccine Candidate Selection Sub-Committee (JKKPCV) chairman, Dr Kalaiarasu M Periasamy.
(pic).
Dr Adham said the Health Ministry was convinced, after a thorough study and assessment, that the benefits of the vaccine outweigh its negatives. The AstraZeneca vaccine is safe to be used for all and it is effective. We will begin using the vaccine on those aged 60 years and above (in Phase Two of the National Covid-19 Immunisation Programme), said Dr Adham at a press conference here on Monday (April 26).
Dr Adham said with the addition of AstraZeneca in Malaysia s Covid-19 vaccine line-up, the country s supply issues could be resolved. We now have many candidates. We already have Pfizer and Sinovac.
Wednesday, 21 Apr 2021 09:30 AM MYT
BY JERRY CHOONG
Health minister Datuk Seri Dr Adham Baba speaks to a reporter during an interview session with Malay Mail at the Ministry of Health in Putrajaya, March 4, 2021. Picture by Shafwan Zaidon
Subscribe to our Telegram channel for the latest updates on news you need to know.
KUALA LUMPUR, April 21 Health Minister Datuk Seri Dr Adham Baba has denied that the government is monopolising the purchase of Covid-19 vaccines, which has resulted in Malaysia experiencing delays in supplies.
Utusan Malaysia reported him as saying that the problem was also not caused by the government’s refusal to involve the private sector, be bullied, or pushed around by the world’s major powers.
COMMENT | Pro-active steps needed for next vaccine rollout
Modified3:49 am
-
COMMENT | The Health Ministry and the Covid-19 Vaccine Supply Access Guarantee Special Committee (JKJAV) must be proactive and ramp up their logistical and administrative preparations during this period in order to both accelerate and smoothen the whole pre-vaccination, vaccination and post-vaccination process of the current Phase 2 and upcoming Phase 3 of the vaccination programme.
This includes ramping up awareness programmes to counter misinformation, hesitancy and concerns raised by the public.
Other steps include increasing the registration rate especially among the vulnerable groups, beefing up call centres for more systemic notification and follow-up, more comprehensive recruitment of non-medical volunteers to manage administrative and logistical issues especially during large-scale vaccinations, and proper training for volunteers on the required standard operating procedures (SOPs).
Monday, 19 Apr 2021 03:53 PM MYT
BY YISWAREE PALANSAMY
A health worker loads a syringe with a dose of the Pfizer-BioTech Covid-19 vaccine at the UiTM Hospital in Sungai Buloh March 2, 2021. ― Picture by Hari Anggara
Subscribe to our Telegram channel for the latest updates on news you need to know.
KUALA LUMPUR, April 19 Science, Technology and Innovation Minister Khairy Jamaluddin today said that there is no data yet to support the need for a third booster shot, to combat the Covid-19 infection.
In a press conference today, Khairy, who also leads the National Covid-19 Immunisation Programme (NIP), was asked about recent remarks by the chief executive of pharmaceutical company, Pfizer, who said that a third dose of his company’s vaccine may likely be needed within six to 12 months after both doses are received.